We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hemolytic, Icteric, and Lipemic Samples Automatically Detected and Managed

By LabMedica International staff writers
Posted on 10 Nov 2009
An analyzer uses preanalytical sample integrity to identify and automatically manage potentially problematic test samples.

Multi-wavelength scanning and sample liquid-sensing technologies detect unsuitable specimens and minimize preanalytical laboratory errors thus helping to obtain high quality results on the first test run. More...
The effects of preanalytical factors can account for up to 70% of a clinical laboratory's errors.

The new generation of coagulation systems automatically detects and manages hemolytic, icteric, and lipemic samples prior to test run. Using preanalytical sample integrity (PSI) technology, the Sysmex CS-2000i system from Siemens Healthcare Diagnostics (Deerfield, IL USA) provides extra operator support by identifying and automatically managing potentially problematic samples prior to analysis. To further maximize workflow, intuitive user-defined software automatically handles results based on user-defined criteria.

The system's simultaneous multiwavelength analytical scanning uses up to five different wavelengths to analyze clotting reactions: 340 nm, 405 nm, 575 nm, 660 nm, and 800 nm. The intelligent system design reduces the need for visual reads and selects the optimal wavelength to reduce the effect of interfering substances. The wide optical spectrum enables measurement of light transmittance over the entire course of the clot formation, not just the end. Thus, atypical reaction patterns can be easily identified to aid in determining the correct coagulation reaction result for patients with unusual in vitro clot reactions such as sepsis or disseminated intravascular coagulation (DIC).

The Sysmex CS-2100i system offers an advanced, third-generation cap-piercing option, intuitive software, troubleshooting software support, and minimal user maintenance. The refrigerated reagent table allows for long on-board stability and reduces the need to remove and place reagents each day while tilted reagent vial positions with positive barcode identification reduce reagent waste. In addition, the robust design with rotating reagent table and short pipettor movements rapidly processes samples and increases system reliability.

Related Links:
Siemens Healthcare Diagnostics




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
ESR Analyzer
TEST1 2.0
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.